Struggle for implementation of new strategies in intensive care medicine: anticoagulation, insulin, and lower tidal volumes
- 30 September 2005
- journal article
- review article
- Published by Elsevier in Journal of Critical Care
- Vol. 20 (3) , 199-204
- https://doi.org/10.1016/j.jcrc.2005.05.007
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Extended Evaluation of Recombinant Human Activated Protein C United States Trial (ENHANCE US)Chest, 2004
- Drug intervention trials in sepsis: divergent resultsThe Lancet, 2004
- Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shockCritical Care Medicine, 2004
- Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe SepsisJAMA, 2003
- An Economic Evaluation of Activated Protein C Treatment for Severe SepsisNew England Journal of Medicine, 2002
- Intensive Insulin Therapy in Critically Ill PatientsNew England Journal of Medicine, 2001
- High-Dose Antithrombin III in Severe SepsisJAMA, 2001
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Disseminated Intravascular CoagulationNew England Journal of Medicine, 1999